COVID-19 | Cyntegrity

Mar 2021

4 Ways to Optimize Vaccine Trials in Coronavirus Variants
Gallery
4 Ways to Optimize Vaccine Trials in Coronavirus Variants

Blog, News

4 Ways to Optimize Vaccine Trials in Coronavirus Variants

By Linda Bunschoten - Chief Marketing Officer|2021-12-22T17:35:37+02:00March 15, 2021|Blog, News|Comments Off on 4 Ways to Optimize Vaccine Trials in Coronavirus Variants

Learn how risk-based quality management (RBQM) helps simplify coronavirus vaccine development and helps mitigate any unnecessary burden from clinical organizations ensuring vaccines are readily available when needed.

FDA Concerned About Statistical Power COVID-19 Impacted Clinical Studies

By Artem Andrianov, Ph.D., MBA|2020-09-29T05:40:58+02:00September 10, 2020|Blog|Comments Off on FDA Concerned About Statistical Power COVID-19 Impacted Clinical Studies

Checking and maintaining trial integrity, and proactively adjusting trial analysis strategies to ensure trial data validity, are the FDA's two key areas of concern.

Q&A | Minds-On Impact COVID-19 on Clinical Trials

By Linda Bunschoten - Chief Marketing Officer|2020-04-08T11:16:07+02:00April 8, 2020|Blog|Comments Off on Q&A | Minds-On Impact COVID-19 on Clinical Trials

We've created this "ask the experts" Q&A to provide clear responses to the questions that were most often asked by the forum's participants.